BioMarin Pharmaceutical (BMRN) EV/EBITDA US GAAP (year values) |
||||||||
2021 | 2022 | 2022 | 2023 | LTM ? | ||||
EV/EBITDA | ? | 337.7 | 114.5 | 70.9 | 58.6 | 0.13 | ||
Changes by years, y/y, % | -112% | -100% | -38% | -17% |
BioMarin Pharmaceutical. EV/EBITDA
BioMarin Pharmaceutical. EV/EBITDA, changes, %
BioMarin Pharmaceutical (BMRN) EV/EBITDA US GAAP (quarter values) |
||||||||
2024Q1 | 2024Q1 | 2024Q2 | 2024Q3 | 2024Q3 | LTM ? | |||
EV/EBITDA | ? | 58.9 | 48.3 | 36.8 | -2.82 | 25.7 | 0.13 | |
Changes by years, y/y, % | -38% | -49% | -53% | -104% | -61% | |||
Changes by quarters, q/q, % | -5% | -18% | -24% | -108% | -1 011% |